T 1085/13 (Amorphous Lercanidipine Hydrochloride / Recordati) du 09.11.2018

Identifiant européen de la jurisprudence: ECLI:EP:BA:2018:T108513.20181109
Date de la décision: 9 novembre 2018
Numéro de l'affaire: T 1085/13
Requête en révision de: -
Numéro de la demande: 06723128.2
Classe de la CIB: A61K 31/435 C07D 211/90 A61P 9/12
Langue de la procédure: Anglais
Distribution: Distribuées aux présidents et aux membres des chambres de recours (B)
Téléchargement: Décision en anglais
Versions JO: Aucun lien JO trouvé
Autres décisions pour cet affaire: -
Résumés pour cette décision: -
Titre de la demande: AMORPHOUS LERCANIDIPINE HYDROCHLORIDE
Nom du demandeur: Recordati Ireland Limited
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a.
Nom de l'opposant: -
Chambre: 3.3.02
Sommaire: -
Dispositions juridiques pertinentes: European Patent Convention Art 52(1)European Patent Convention Art 54 European Patent Convention Art 56
Mots-clés: Novelty - (yes)
Inventive step - (yes)
Exergue: A claim defining a compound as having a certain purity lacks novelty over a prior-art disclosure describing the same compound only if the prior art discloses the claimed purity at least implicitly, for example by way of a method for preparing said compound, the method inevitably resulting in the purity as claimed.
Such a claim, however, does not lack novelty if the disclosure of the prior art needs to be supplemented, for example by suitable (further) purification methods allowing the skilled person to arrive at the claimed purity.
The question of whether such (further) purification methods for the prior-art compound are within the common general knowledge of those skilled in the art and, if applied, would result in the claimed purity, is not relevant to novelty, but is rather a matter to be considered in the assessment of inventive step (reasons, 3.7, 3.8).
Affaires citées: G 0002/88 G 0002/10 T 0296/87 T 0990/96 T 0728/98 T 1523/07 T 2522/10 T 1383/12 T 1723/12 T 0049/13 T 0648/13 T 0572/14 T 2267/14 T 1890/15
Affaires citantes: T 0492/14 T 1914/15 T 0474/17 T 0853/17 T 0043/18 T 0552/18 T 0454/19 T 1245/19 T 1688/20 T 1756/21 T 2052/22

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the examining division with the order to grant a patent with the following claims and a description to be adapted thereto:

Claims 1 to 3 of the main request filed during the oral proceedings of 9 November 2018.